Product Information
BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by PAI Holdings LLC, priced at $0.0804 per ML under NDC 00121093304. Its NADAC has been published 220 times since Jun 8, 2022.
FDA first approved this application on Jul 21, 2014. Its Orange Book therapeutic-equivalence code is AA.
BROMPHEN-PSE-DM 2-30-10 MG/5 ML
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan HydrobromideStrength
2; 10; 30 mg/5mL; mg/5mL; mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121093304
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202940FDA Approved
7/21/2014
TE Code
AA
On Market Since
3/3/2022
Pharmacological Classes
Price Statistics
The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 220 times since Jun 8, 2022, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0804 per ML |
|---|---|
| All-time high | $0.1194 (Dec 13, 2023) |
| All-time low | $0.0594 (Apr 17, 2024) |
| 52-week high | $0.0868 |
| 52-week low | $0.0744 |
| Median price | $0.0826 |
| Average price | $0.0837 |
| Largest weekly change | +60.3% (Nov 22, 2023) |
| Weeks tracked | 220 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by PAI Holdings LLC, is $0.0804 per ML (NDC 00121093304), effective Aug 19, 2026.
How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?
Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has risen 8.4%. It has been tracked across 220 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Since Jun 8, 2022, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0594 (Apr 17, 2024) to a high of $0.1194 (Dec 13, 2023), with a median of $0.0826 per ML.
Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMPHEN-PSE-DM 2-30-10 MG/5 ML, is $0.0714 per ML — about 11% below BROMPHEN-PSE-DM 2-30-10 MG/5 ML.
Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 00121093304) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.